NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT02419495 2025-06-04Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Terminated221 enrolled
NCT02922764 2025-03-26A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerInspirna, Inc.Phase 1 Completed146 enrolled
NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT01172028 2015-12-03Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsUniversity of ArizonaPhase 1 Completed33 enrolled
NCT00315861 2009-01-23Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesSCRI Development Innovations, LLCPhase 1 Completed15 enrolled